1.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 21
Sponsor: Other
Protocol IDs: PK01/16/08, NCT00808184
|
|
2.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SG 327/10, NCT01402089
|
|
3.
|
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 20110920A, NCT01499836
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-08-037, NCT01157598
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 19 and over
Sponsor: Other
Protocol IDs: FHREB 2012-057, NCT01687751
|
|
6.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107A2128, 2009-009425-28, NCT01223898
|
|
7.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399
|
|
8.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INT12497, U1111-1125-8930, NCT01585623
|
|
9.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTKI258A2119, 2011-001489-16, NCT01596647
|
|
10.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13517, I6A-MC-CBBA, NCT01655225
|
|
11.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 10-610, NCT01179308
|
|
12.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RCCS 262, NCT01488045
|
Mobile | Español
